DecisionDx-SCC
40-gene expression profile with clinicopathologic integration for metastatic-risk stratification in high-risk cutaneous SCC.
- Developer
- Castle Biosciences
- Intended use
- Risk Stratification
- Cancer scope
- Not reported
- Specimen
- FFPE tumor tissue
- Molecular modality
- RNA expression
- Current version
- Current integrated DecisionDx-SCC
- Evidence context
- 1 structured studies · 0 indexed performance results · 1 sources
Why can reported performance numbers differ? MDI keeps each result attached to its study, population, stage or stratum, test version and source rather than treating performance as a fixed property of the test.